Al: ATM means "at the market". In this case ZLCS contracted with MTM to sell $15,000,000 worth of stock to raise cash to cover 2 non-reoccurring costs this year. Some, including me, think it was a very savvy and wise move. The first move was to farm out 2 years worth of clinical trials and the second was to shut down the R&D facility in Vancouver as it had served its purpose. ZLCS was on the cusp of ending up with too many irons in the fire and it made little sense to keep funding Vancouver and cause a cash drain that could only provide more and deeper R&D projects. ZLCS would not have been able to support more at that time. That's all I'm going to pass out on this. For more complete information go the ZALICUS web site and start reading the investor info pages (if I were you I read every thing on their site) and do some easy D&D. You really don't need to go digging everywhere to see what ZALICUS is all about its pretty much posted on the site. Jim Long and calm
A good example of too many irons in the fire is VICL. They decided to concentrate mostly on a cancer drug, which may or may not turn out well. They have a potential herpes vaccine and many other possible biggies, but have had questionable focus.